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ABSTRACT
Cardiovascular disease is the main cause of death in Cuba, yet the prevalence of novel risk factors is not 
known. To examine the prevalence of risk factors of traditional and novel cardiovascular diseases (CVDs) 
among an urban Cuban population, a cross-sectional pilot survey was undertaken in Havana city, Cuba. 
Ninety-seven adults aged 45-60 years registered to receive medical care at a policlinic. The prevalences of 
rates of CVD risk factors were: hypertension (≥140/90 mmHg) (53.6%), hypercholesterolaemia (total cho-
lesterol >5.2 mmol/L) (47.0%), low high-density lipoprotein (HDL)-cholesterol (<1.03 mmol/L) (64.3%); 
diabetes (self-reported) (24.6%); metabolic syndrome (ATP III criteria) (58.2%); overweight and obesity 
(body mass index ≥25 kg/m2) (78.0%); current smoking (39.3%); elevated level of C-reactive protein (3 
<value <10 mg/L) (32.1%), low lipid-standardized vitamin E levels (<5 µmol/mmol of total cholesterol) 
(69.6%); and high tHcy levels (>15 µmol/L) (11.1%). The total carotenoid status was independently associa-
ted with waist-circumference and risk of diabetes and metabolic syndrome. In this small unrepresentative 
sample of people aged 40-65 years from Havana city, there was a high prevalence of traditional and novel 
CVD risk factors.  The total serum carotenoid status appeared to be associated with an increased prevalence 
of CVD risk factors. 
Key words: Cardiovascular diseases; Carotenoids; Cross-sectional studies; Obesity; Risk factors; Cuba
INTRODUCTION
Cardiovascular diseases (CVDs) are the main cause 
of death in Cuba (1). Although the mortality rates 
have decreased in the last 15-20 years, the mortali-
ty rates are still among the highest in the Americas 
(2). There is also a high prevalence of overweight 
and obesity in Cuba (3). The observed reduction in 
mortality due to CVDs has been less than would 
have been expected from the reduction in total se-
rum cholesterol levels, and it has been proposed 
that this could be due to more novel CVD risk fac-
tors (4). The proposed novel risk factors for CVDs 
include the inflammatory marker C-reactive pro-
tein (CRP) (5,6) and dietary factors, such as carote-
noid and vitamin B status (7,8). However, there is 
currently no information on the role of these novel 
cardiovascular risk factors in determining CVD risk 
in Cuba.
The aim of this pilot study was to assess potentially 
novel risk factors for CVD in an adult population in 
Cuba and to determine how these novel risk factors 
were associated with classical CVD risk factors.
MATERIALS AND METHODS
Study design  
Ninety-seven adults, aged 45-60 years, receiving 
medical care in a policlinic (primary healthcare 
setting) in Havana were recruited. The exclusion 
criteria were adults with non-atherosclerotic CVD, 
current pregnancy, women breastfeeding, psy-
chiatric disorders, cardiomyopathy, acute inflam-
matory conditions, acute malnutrition, systemic 
rheumatic diseases, gout, known chronic and acute 
renal failures, nephrotic syndrome, thyroid dis-
orders, cancer, and HIV-positive or AIDS. Eligible Status of CVD risk factors in Cuba Rodriguez-Ojea A et al.
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participants were invited to participate by three 
of 15 family doctors employed within the clinic, 
representing 20% of the total population within 
relevant age range registered at the clinic. Trained 
general practitioners and nurses examined them 
for traditional and novel cardiovascular risk factors. 
A general questionnaire, including parental and 
personal medical records, was completed by the 
family doctor. Physical activity was assessed using 
the question “Compared to your friends and peo-
ple of your age, how would you consider your 
physical activity: less than, same as, more than?” 
Anthropometric data included height and weight, 
from which body mass index (BMI) in kg/m2 was 
calculated. Waist-circumference and hip-circumfer-
ence were measured according to the established 
protocols, and the waist-to-hip ratio was calculated. 
Fasting serum samples were collected and stored at 
-80 °C until analysis. Medical history, including 
record of psychiatric disorders, gout, acute malnu-
trition, cancer, rheumatic disease, neurologic and 
demyelinating disorders, acute and chronic renal 
failures, nephrotic syndrome, thyroid diseases, and 
HIV or AIDS, was also noted. Presence or absence of 
metabolic syndrome was defined according to the 
Adult Treatment Panel III criteria (9). 
Laboratory methods
Levels of vitamin A and E and carotenoids in serum 
were assessed using high-performance liquid chro-
matography (HPLC) with diode array detection 
following extraction into heptanes (10). CRP was 
assessed by latex-enhanced immunoturbidimetric 
assay (Randox Pharmaceuticals, UK) using an ILab 
600 biochemical analyzer and using the I-Lab 600 
computer software (Instrumentation Laboratories 
Ltd., Warrington, UK). Serum lipids (total choles-
terol, high-density lipoprotein (HDL)-cholesterol, 
and triglycerides) were analyzed using enzymatic 
assays (Randox Ltd., Crumlin, NI) on an I-Lab 600 
autoanalyser. tHcy was determined by HPLC with 
detection of fluorescence according to Ubbink et 
al. (11). Serum folate and vitamin B12 were deter-
mined using a SimulTRAC-SNB radioassay kit (ICN 
Pharmaceuticals, California, USA). The QUICKI and 
HOMA scores, as measures of insulin resistance, 
were calculated from fasting glucose and insulin 
measures (12,13). The HOMA score is fasting plas-
ma insulin (mIU/L) x fasting plasma glucose/22.5 
while the QUICKI score is equal to 1/[log fasting 
plasma insulin (µU/mL) + log fasting plasma glu-
cose (mg/dL)].
Statistical methods
Continuous data were assessed for normality and 
logarithmically transformed where appropriate. 
Data were compared between sexes, or according 
to published cut-off points for increased CVD risk 
using Student’s independent samples t-test (contin-
uous variables) or chi-square test (categorical vari-
ables). The associations between the continuous 
variables were examined using Pearson’s correlation 
co-efficients. Multivariate analysis was carried out 
using general linear modelling (continuous vari-
able outcomes) or logistic regression (categorical 
variable outcomes). Confounders were included if 
they were independently associated with the varia-
ble of interest, or were known to be associated with 
the variable from the scientific literature. A p value 
of <0.05 was considered significant. All statistical 
analyses were performed using the SPSS software 
for Windows (version 17.0).
Ethical aspects
The study was conducted in accordance with the 
Helsinki Declaration.
RESULTS
The overall risk factors and the disease-preva-
lence rates were: hypertension (≥140/90 mmHg) 
(53.6%); hypercholesterolaemia (total cholesterol 
>5.2 mmol/L) (47.0%); low-HDL-cholesterol (<1.03 
mmol/L) (64.3%); diabetes (self-reported) (24.6%); 
metabolic syndrome (ATP III criteria) (58.2%); 
overweight and obesity (BMI ≥25 kg/m2) (78.0%); 
current smoking (39.3%); elevated levels of CRP (3 
<value <10 mg/L) (32.1%); low lipid-standardized 
vitamin E levels (<5 µmol/mmol total choles-
terol) (69.6%); and high tHcy levels (>15 µmol/L) 
(11.1%).
The distribution of demographic variables and 
traditional CVD risk factors is presented by sex in 
Table 1 and of more novel risk factors by sex in 
Table 2. Women had a significantly lower waist-
circumference and waist-to-hip ratio and higher 
HDL-cholesterol but also higher total cholesterol. 
A higher proportion reported being diabetic and 
women reported taking less physical activity than 
men. The folate status was significantly higher in 
women than in men but the α-carotene status was 
significantly lower in women than in men.
We then explored how closely the novel risk factors 
assessed were associated with the traditional CVD 
and diabetes risk factors. Of the novel risk factors as-
sessed, the total carotenoid status was most closely 
associated with the status of traditional risk factor 
in unadjusted analyses, being negatively associated 
with BMI (r=-0.38, p<0.01), waist-circumference 
(r=-0.36, p=0.01), triglycerides (r=-0.25, p<0.05), 
and HOMA score (r=-0.26, p<0.05) and positively Rodriguez-Ojea A et al. Status of CVD risk factors in Cuba
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Table 1. Description of demographic variables and traditional CVD risk factors by sex in a middle-
aged Cuban population
Variable or risk factor Males (nmax=46) Females (nmax=51) p value
Age (years) 54.7 (6.0) 54.1 (6.7) 0.61
Systolic blood pressure (mmHg) 139.0 (15.1) 143.6 (23.3) 0.36
Diastolic blood pressure (mmHg) 83.2 (8.4) 85.1 (11.9) 0.48
Hypertensive (>140/90 mmHg)






Body mass index (kg/m2) 27.5 (4.0) 29.5 (5.9) 0.14
% of normal weight (<25 kg/m2)
% of overweight (25-29.9 kg/m2)








Waist-circumference (cm) 98.4 (10.6) 91.7 (12.0) 0.03
Waist-to-hip ratio 0.95 (0.06) 0.85 (0.06) <0.001
Total cholesterol (mmol/L) 4.96 (1.03) 5.42 (1.03) 0.047
HDL-cholesterol (mmol/L) 0.86 (0.26) 1.03 (0.36) 0.02
Triglycerides (mmol/L) 1.88 (0.66) 1.90 (0.68) 0.89
% of current smokers 32.5 44.9 0.23
% of diabetics 11.1 33.3 0.04













% perceived self less active than others
% perceived self equally active to others








Data presented as mean (SD) for continuous variables or % for categorical variables. P value is 
given for the comparison of males and females. This was determined using an independent sample 
t-test for continuous variables and a chi-square test for categorical variables. CVD=Cardiovascular 
disease; HDL=High-density lipoprotein cholesterol; SD=Standard deviation
Table 2. Description of novel CVD risk factors and biomarkers of nutritional status by sex in a 
middle-aged Cuban population
Novel biomarker or CVD 
risk factor
Males (nmax=46) Females (nmax=51) p value
QUICKI 0.35 (0.04) 0.35 (0.05) 0.71
HOMA 2.12 (1.01, 4.66) 1.98 (1.12, 3.56) 0.72
CRP (mg/L) 2.56 (1.34, 4.80) 2.49 (1.12, 5.11) 0.90
tHcy (µmol/L) 10.6 (8.3, 12.4) 9.2 (7.4, 11.2) 0.16
Folate (nmol/L) 19.3 (12.9, 27.5) 24.5 (18.6, 30.6) 0.03
Vitamin B12 (pmol/L) 309.8 (181.0, 471.7) 330.2 (214.0, 471.2) 0.63
Lipid standardized vitamin E (µmol/mmol) 4.53 (1.41) 4.72 (1.63) 0.59
Total carotenoids (µmol/L) 0.85 (0.63, 1.36) 0.85 (0.56, 1.28) 0.99
α-carotene (µmol/L) 0.08 (0.05, 0.13) 0.05 (0.03, 0.09) 0.048
β-carotene (µmol/L) 0.19 (0.13, 0.31) 0.21 (0.13, 0.34) 0.66
Data presented as mean (SD) for continuous variables, except for HOMA score, CRP, tHcy, folate, vitamin 
B12, total carotenoid status, α-carotene and β-carotene status where variables were logarithmically 
transformed and presented as geometric mean (interquartile range). P value is given for the comparison 
of males and females. This was determined using an independent sample t-test for continuous variables 
and a chi-square test for categorical variables. CRP=C-reactive protein; CVD=Cardiovascular disease; 
SD=Standard deviation Status of CVD risk factors in Cuba Rodriguez-Ojea A et al.
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associated with tHcy (r=0.31, p<0.01) and QUICKI 
score (r=0.26, p=0.03). The total carotenoid status 
was significantly lower in diabetics compared to 
non-diabetics [diabetics 0.592 (1.74); non-diabetics 
0.925 (1.68), p=0.01]; lower in those with meta-
bolic syndrome versus those without metabolic 
syndrome [metabolic syndrome 0.721 (1.69); with-
out metabolic syndrome 0.970 (1.66), p=0.03] and 
differed among BMI categories, being higher in 
those of normal weight than in those who were 
overweight or obese [normal weight 1.221 (1.46); 
overweight 0.831 (1.63); and obese 0.679 (1.86), 
p=0.02]. The total carotenoid status did not differ 
between smokers and non-smokers [non-smokers 
0.895 (1.66); smokers 0.740 (1.87), p=0.17].
The variables described above in univariate analyses 
were entered into separate multivariate regression 
models with the traditional risk factor or condition 
as the dependent variable and the total carotenoid 
status as an explanatory variable. These models 
were initially adjusted for age, sex, cholesterol, and 
smoking status, and then additionally for ethnic 
origin, carotene intake, physical activity, hyperc-
holesterolaemia, and hypertension (Table 3). The 
total carotenoid status was significantly negatively 
associated with waist-circumference and BMI after 
initial adjustment, and this remained significant 
for waist-circumference but just lost significance 
for BMI (p=0.054) after further adjustment. Simi-
larly, in logistic regression models, with diabetes 
or metabolic syndrome as outcome variables, the 
total carotenoid status was significantly associated 
with risk of being diabetic [Exp(B)=-0.035, p=0.04] 
or having metabolic syndrome [Exp(B)=-0.035, 
p=0.035] (logistic regression analyses only adjusted 
for age, sex, total cholesterol, and smoking status).
DISCUSSION
This study has examined the traditional and novel 
CVD risk factor status of urban people aged 40-65 
years in Cuba. In general, there was a high preva-
lence of traditional CVD risk factors in particular, 
such as hypertension, high cholesterol, low-HDL-
cholesterol, and smoking, and a high prevalence of 
metabolic syndrome. The total serum carotenoid 
status was the novel CVD risk factor most closely 
associated with an increased prevalence of CVD 
risk factors.
Rodriguez et al. recently examined the trends in 
mortality due to coronary heart diseases (CHDs) in 
the Americas during 1970-2000 (2), and although 
reduction in mortality due to CHDs was observed 
for Cuba, the rates of mortality due to CHDs in 
Cuba were still the highest among women com-
pared to other countries in the Americas and the 
third highest in men. The authors concluded that 
recent reductions in mortality due to CHDs were 
less favourable in Latin America than in the USA 
and Canada and that this may reflect unfavourable 
changes in nutrition (including obesity), physical 
activity, and smoking, together with less-effective 
control of hypertension and management of 
CHDs.
Cuba experienced an economic crisis in the early 
1990s, triggered by the collapse of the Soviet Union 
and a reinforced US blockade and characterized by 
a shortage of fuel, food and essential supplies (4,14). 
Per-capita energy availability and physical activity 
increased, and the prevalence of obesity decreased. 
This was followed by a period of economic recov-
ery, and Cuba now occupies an unusual position as 
a non-industrialized country with a well-developed 
public-health sector, which has eliminated epidem-
ic infectious diseases, has low infant mortality, and 
a long life expectancy (15). To our knowledge, this 
is the first study to examine both traditional and 
novel risk factor status in a Cuban population since 
the nutrition transition in the 1990s.  
Even for the traditional CVD risk factors, there are 
few published data with which to compare our re-
sults. Cooper et al. have summarized the available 
data (15). Our overall prevalence rates for hyper-
tension (age-group: 40-65 years; 53.6%) were some-
what higher than that reported in other literature 
[15-74 years; 25% (16) and (35-64 years; 34%) (17)] 
but this may reflect the urban centre from which 
we recruited our sample, the more recent sampling 
Table 3. Average increase in CVD and diabetes-related risk factors per one unit increase (on the log scale) 





  Model 2
Mean (95% CI)
p value
BMI -8.2 (-14.4,-2.1) p=0.01 -7.9 (-5.9, 0.2) 0.054
Waist-circumference -21.0 (-34.5,-7.5) p=0.003 -21.2 (-39.4,-3.0) 0.026
Waist-to-hip ratio -0.04 (-0.11, 0.03) p=0.21 -0.05 (-0.17, 0.08) 0.46
Model 1=Adjusted for age, sex, cholesterol, and smoking status; Model 2=Additionally adjusted for 
ethnic origin, carotene intake, physical activity, hypercholesterolaemia, and hypertension. BMI=Body 
mass index; CI=Confidence interval; CVD=Cardiovascular disease Rodriguez-Ojea A et al. Status of CVD risk factors in Cuba
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time, and the slightly older age range used. The cur-
rent smoking status was similar in our population 
to other reports (15). The obesity rates in the present 
study were also somewhat higher than what had 
been reported previously (23% of males and 45% 
females compared to 8% of males and 14% of fe-
males) (16), with reasons for these differences likely 
to be as for hypertension. Our data relating to lipid 
concentrations and the prevalence of metabolic 
syndrome are, to our knowledge, among the first to 
be reported in the last decade.
For the more novel risk factors, even fewer com-
parisons with published literature can be drawn. 
Cut-points for the increased CHD risk remain to be 
firmly established for many of these factors but for 
lipid-standardized vitamin E and tHcy, cut-points 
of 5 µmol/mmol (18) and 15 µmol/L (19) have 
been suggested respectively. In the present study, 
using these cut-points, 69.6% and 11.1% of the 
population can be considered at an elevated risk of 
CHD based on lipid-standardized vitamin E and 
tHcy. For CRP, the American Heart Association has 
suggested that the serum CRP values of >10 mg/L 
imply the presence of active infection or inflam-
mation but that values between 3 and 10 mg/L are 
indicative of an increased risk of CVDs (20). Using 
this cut-point suggests that just under one-third of 
this population is at an increased risk of CVDs in 
terms of CRP concentrations.
The consistent associations observed between the 
total carotenoid status and the traditional risk fac-
tors for CVDs and diabetes and risk of diabetes 
and metabolic syndrome are of interest and have 
recently been reported in a number of larger epi-
demiological studies. Akbaraly et al. reported that 
elderly subjects in the highest quartile of total 
plasma carotenoids had a reduced nine-year risk 
of dysglycaemia compared to participants in the 
lowest quartile [relative risk (RR)=0.42, 95% con-
fidence interval (CI) 0.22-0.82], and the same in-
vestigators also demonstrated an association with 
mortality (22). Similarly, in a cross-sectional analy-
sis of middle-aged and older women, Wang et al. 
showed an association between individual plasma 
carotenoids, although they did not look at total 
carotenoid status, smoking, obesity, low-density 
lipoprotein-cholesterol (LDL), HDL-cholesterol, 
HbA1c, and CRP (23). Finally, Farwell et al. demon-
strated a cross-sectional association between total 
plasma carotenoids and current smoking, alcohol 
ingestion, lipids (total-, HDL- and LDL-cholesterol), 
and ICAM-1 in middle-aged men (24). It is not ap-
parent from any of these studies whether the total 
plasma or serum carotenoid status is serving as a 
marker of a diet high in fruit and vegetable con-
sumption, as a marker of other protective lifestyle 
habits and health behaviours, or whether they are 
directly having an effect of CVD risk factors but 
these relatively consistent associations do deserve 
further exploration.  
Limitations
The present study had several limitations. It was 
a small and cross-sectional study in nature, and 
therefore, no causal relationships can be directly as-
sessed. It was also not taken from a truly represent-
ative sample of the Cuban population but served as 
a pilot study of the application of epidemiological 
research methods and the determination of novel 
cardiovascular risk factor status in Cuba. For that 
reason, the conclusions are only valid for the popu-
lation studied (i.e. patients aged 45-60 years from 
an urban setting) and cannot be extrapolated to 
other Cuban populations. As numbers were small, 
the conclusions must also be interpreted cautious-
ly, as the multivariate adjustment carried out, with 
adjustment for up to nine covariates, may have 
produced false significant associations. Neverthe-
less, it is one of the first studies since the nutrition 
transition in the 1990s to examine the status of tra-
ditional CVD risk factors and the status of novel 
CVD risk factors. It has also examined how the sta-
tus of novel cardiovascular risk factors in a Cuban 
population relates to the status of traditional car-
diovascular risk factors.  
Conclusions 
In this small unrepresentative population sample, 
classical CVD risk factors were highly prevalent 
among people aged 40-65 years in Havana city. The 
main traditional risk factors present were hyperten-
sion, low-HDL-cholesterol, and overweight/obesity 
while over one-third of this population was at any 
elevated risk of CVDs through high CRP concentra-
tions and more than two-thirds at an elevated risk 
in terms of their lipid-standardized vitamin E sta-
tus. The total serum carotenoid status in this small 
sample appeared to be inversely associated with an 
increased prevalence of CVD risk factors. 
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